We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$712B
AUM Growth
+$77.7B
Cap. Flow
+$6.45B
Cap. Flow %
0.91%
Top 10 Hldgs %
29.74%
Holding
13,792
New
1,607
Increased
5,174
Reduced
5,388
Closed
1,330

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.51B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.53B
3
AMZN icon
Amazon
AMZN
+$1.11B
4
ABNB icon
Airbnb
ABNB
+$574M
5
NVDA icon
NVIDIA
NVDA
+$519M

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.77%
2 Consumer Discretionary 1.94%
3 Technology 1.9%
4 Communication Services 1.42%
5 Financials 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEGAU
10601
DELISTED
Lead Edge Growth Opportunities, Ltd Units
LEGAU
$314K ﹤0.01%
+31,384
New +$314K
ASB icon
10602
PUT
Associated Banc-Corp
ASB
$5.85B
$313K ﹤0.01%
15,300
-14,500
-49% -$320K
ASHS icon
10603
Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF
ASHS
$34.5M
$313K ﹤0.01%
+8,177
New +$301K
BV icon
10604
CALL
BrightView Holdings
BV
$1.03B
$313K ﹤0.01%
19,400
-400
-2% -$7.02K
CBT icon
10605
PUT
Cabot Corp
CBT
$4.38B
$313K ﹤0.01%
5,500
-4,900
-47% -$288K
CYCN icon
10606
Cyclerion Therapeutics
CYCN
$18.7M
$313K ﹤0.01%
4,009
+2,627
+190% +$164K
DSL
10607
CALL
DoubleLine Income Solutions Fund
DSL
$1.23B
$313K ﹤0.01%
17,300
-12,900
-43% -$234K
NEOG icon
10608
PUT
Neogen
NEOG
$2.54B
$313K ﹤0.01%
6,800
-13,800
-67% -$638K
PAHC icon
10609
Phibro Animal Health
PAHC
$1.55B
$313K ﹤0.01%
+10,836
New +$293K
RWJ icon
10610
CALL
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.08B
$313K ﹤0.01%
7,800
+2,100
+37% +$83K
CYXT
10611
PUT
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
$313K ﹤0.01%
+31,300
New +$312K
SEAH
10612
CALL
DELISTED
Sports Entertainment Acquisition Corp.
SEAH
$313K ﹤0.01%
+31,100
New +$314K
KIN
10613
PUT
DELISTED
Kindred Biosciences, Inc.
KIN
$313K ﹤0.01%
34,100
-24,000
-41% -$140K
ASMB icon
10614
Assembly Biosciences
ASMB
$697M
$312K ﹤0.01%
6,707
+3,902
+139% +$193K
EDIV icon
10615
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.24B
$312K ﹤0.01%
+10,422
New +$317K
EXPO icon
10616
CALL
Exponent
EXPO
$3.38B
$312K ﹤0.01%
+3,500
New +$328K
ITT icon
10617
ITT
ITT
$18.5B
$312K ﹤0.01%
+3,409
New +$317K
LILA icon
10618
PUT
Liberty Latin America Class A
LILA
$1.65B
$312K ﹤0.01%
33,120
+11,776
+55% +$112K
IRD
10619
Opus Genetics
IRD
$315M
$312K ﹤0.01%
+59,172
New +$294K
HYLD
10620
PUT
DELISTED
High Yield ETF
HYLD
$312K ﹤0.01%
+9,600
New +$312K
ABG icon
10621
Asbury Automotive
ABG
$3.8B
$311K ﹤0.01%
1,816
-8,798
-83% -$1.69M
BOND icon
10622
PUT
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.59B
$311K ﹤0.01%
2,800
-7,700
-73% -$849K
IYJ icon
10623
iShares US Industrials ETF
IYJ
$1.91B
$311K ﹤0.01%
2,799
-26,074
-90% -$2.88M
SPLB icon
10624
PUT
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.22B
$311K ﹤0.01%
9,800
+800
+9% +$24.6K
TMP icon
10625
Tompkins Financial
TMP
$1.41B
$311K ﹤0.01%
+4,005
New +$322K

Similar funds

Jeff Yass's Q2 2021 Portfolio in Review

As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
  • Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
  • Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
  • Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
  • Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
  • Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
  • Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.